Track the 株式会社フェニックスバイオ stock price and the full management transaction log of the company, a listed equity based in Japan. Shares are listed on the JP market, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社フェニックスバイオ has published 30 reports. Market capitalisation: €1.4bn. The latest transaction was reported on 29 September 2025 (Holding update). Among the most active insiders: Whiz Partners Inc.. All data is accessible without an account.
30
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
20Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,480 of 29,062 companies
63.6
score / 100
Value
66
Quality
62
FCF yld3.8%
Earn yld8.8%
EV/EBITDA11.2x
ROE8.6%
Gross mgn77%
Net mgn8.0%
Debt/EBITDA2.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.